Click for best price
Hepatitis A B Vaccine Market Size, Share 2022
The hepatitis A and hepatitis B vaccines?can be given separately or as a combination vaccine. All the shots in the series are needed for long-term protection. The full series of the hepatitis A and hepatitis B vaccines require 2-3 shots, depending on the type of vaccine.
This report contains market size and forecasts of Hepatitis A and B Vaccine in global, including the following market information:
Global Hepatitis A and B Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hepatitis A and B Vaccine Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Hepatitis A and B Vaccine companies in 2021 (%)
The global Hepatitis A and B Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hepatitis A Vaccination Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis A and B Vaccine include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis A and B Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis A and B Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Hepatitis A and B Vaccine Market Segment Percentages, by Type, 2021 (%)
Hepatitis A Vaccination
Hepatitis B Vaccination
Global Hepatitis A and B Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Hepatitis A and B Vaccine Market Segment Percentages, by Application, 2021 (%)
Government Institution
Private Sector
Other
Global Hepatitis A and B Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Hepatitis A and B Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis A and B Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hepatitis A and B Vaccine revenues share in global market, 2021 (%)
Key companies Hepatitis A and B Vaccine sales in global market, 2017-2022 (Estimated), (Units)
Key companies Hepatitis A and B Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
| Report Attributes |
Report Details |
| Report Title |
Hepatitis A and B Vaccine Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis A and B Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis A and B Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis A and B Vaccine Overall Market Size
2.1 Global Hepatitis A and B Vaccine Market Size: 2021 VS 2028
2.2 Global Hepatitis A and B Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hepatitis A and B Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Hepatitis A and B Vaccine Players in Global Market
3.2 Top Global Hepatitis A and B Vaccine Companies Ranked by Revenue
3.3 Global Hepatitis A and B Vaccine Revenue by Companies
3.4 Global Hepatitis A and B Vaccine Sales by Companies
3.5 Global Hepatitis A and B Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hepatitis A and B Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hepatitis A and B Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis A and B Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis A and B Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis A and B Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis A and B Vaccine Market Size Markets, 2021 & 2028
4.1.2 Hepatitis A Vaccination
4.1.3 Hepatitis B Vaccination
4.2 By Type - Global Hepatitis A and B Vaccine Revenue & Forecasts
4.2.1 By Type - Global Hepatitis A and B Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Hepatitis A and B Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Hepatitis A and B Vaccine Sales & Forecasts
4.3.1 By Type - Global Hepatitis A and B Vaccine Sales, 2017-2022
4.3.2 By Type - Global Hepatitis A and B Vaccine Sales, 2023-2028
4.3.3 By Type - Global Hepatitis A and B Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Hepatitis A and B Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Hepatitis A and B Vaccine Market Size, 2021 & 2028
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application - Global Hepatitis A and B Vaccine Revenue & Forecasts
5.2.1 By Application - Global Hepatitis A and B Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Hepatitis A and B Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Hepatitis A and B Vaccine Sales & Forecasts
5.3.1 By Application - Global Hepatitis A and B Vaccine Sales, 2017-2022
5.3.2 By Application - Global Hepatitis A and B Vaccine Sales, 2023-2028
5.3.3 By Application - Global Hepatitis A and B Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Hepatitis A and B Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Hepatitis A and B Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis A and B Vaccine Revenue & Forecasts
6.2.1 By Region - Global Hepatitis A and B Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Hepatitis A and B Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Hepatitis A and B Vaccine Sales & Forecasts
6.3.1 By Region - Global Hepatitis A and B Vaccine Sales, 2017-2022
6.3.2 By Region - Global Hepatitis A and B Vaccine Sales, 2023-2028
6.3.3 By Region - Global Hepatitis A and B Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Hepatitis A and B Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Hepatitis A and B Vaccine Sales, 2017-2028
6.4.3 US Hepatitis A and B Vaccine Market Size, 2017-2028
6.4.4 Canada Hepatitis A and B Vaccine Market Size, 2017-2028
6.4.5 Mexico Hepatitis A and B Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Hepatitis A and B Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Hepatitis A and B Vaccine Sales, 2017-2028
6.5.3 Germany Hepatitis A and B Vaccine Market Size, 2017-2028
6.5.4 France Hepatitis A and B Vaccine Market Size, 2017-2028
6.5.5 U.K. Hepatitis A and B Vaccine Market Size, 2017-2028
6.5.6 Italy Hepatitis A and B Vaccine Market Size, 2017-2028
6.5.7 Russia Hepatitis A and B Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Hepatitis A and B Vaccine Market Size, 2017-2028
6.5.9 Benelux Hepatitis A and B Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Hepatitis A and B Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Hepatitis A and B Vaccine Sales, 2017-2028
6.6.3 China Hepatitis A and B Vaccine Market Size, 2017-2028
6.6.4 Japan Hepatitis A and B Vaccine Market Size, 2017-2028
6.6.5 South Korea Hepatitis A and B Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Hepatitis A and B Vaccine Market Size, 2017-2028
6.6.7 India Hepatitis A and B Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Hepatitis A and B Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Hepatitis A and B Vaccine Sales, 2017-2028
6.7.3 Brazil Hepatitis A and B Vaccine Market Size, 2017-2028
6.7.4 Argentina Hepatitis A and B Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatitis A and B Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Hepatitis A and B Vaccine Sales, 2017-2028
6.8.3 Turkey Hepatitis A and B Vaccine Market Size, 2017-2028
6.8.4 Israel Hepatitis A and B Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Hepatitis A and B Vaccine Market Size, 2017-2028
6.8.6 UAE Hepatitis A and B Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis A and B Vaccine Major Product Offerings
7.1.4 GSK Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 GSK Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Hepatitis A and B Vaccine Major Product Offerings
7.2.4 Merck Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Hepatitis A and B Vaccine Major Product Offerings
7.3.4 Sanofi Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Sinovac
7.4.1 Sinovac Corporate Summary
7.4.2 Sinovac Business Overview
7.4.3 Sinovac Hepatitis A and B Vaccine Major Product Offerings
7.4.4 Sinovac Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Sinovac Key News
7.5 Zhejiang Pukang
7.5.1 Zhejiang Pukang Corporate Summary
7.5.2 Zhejiang Pukang Business Overview
7.5.3 Zhejiang Pukang Hepatitis A and B Vaccine Major Product Offerings
7.5.4 Zhejiang Pukang Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Zhejiang Pukang Key News
7.6 Changchun Institute of Biological
7.6.1 Changchun Institute of Biological Corporate Summary
7.6.2 Changchun Institute of Biological Business Overview
7.6.3 Changchun Institute of Biological Hepatitis A and B Vaccine Major Product Offerings
7.6.4 Changchun Institute of Biological Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Changchun Institute of Biological Key News
7.7 KM Biologics
7.7.1 KM Biologics Corporate Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis A and B Vaccine Major Product Offerings
7.7.4 KM Biologics Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 KM Biologics Key News
7.8 IMBCAMS
7.8.1 IMBCAMS Corporate Summary
7.8.2 IMBCAMS Business Overview
7.8.3 IMBCAMS Hepatitis A and B Vaccine Major Product Offerings
7.8.4 IMBCAMS Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 IMBCAMS Key News
7.9 Convac
7.9.1 Convac Corporate Summary
7.9.2 Convac Business Overview
7.9.3 Convac Hepatitis A and B Vaccine Major Product Offerings
7.9.4 Convac Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Convac Key News
7.10 NCPC
7.10.1 NCPC Corporate Summary
7.10.2 NCPC Business Overview
7.10.3 NCPC Hepatitis A and B Vaccine Major Product Offerings
7.10.4 NCPC Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 NCPC Key News
7.11 Bio Kangtai
7.11.1 Bio Kangtai Corporate Summary
7.11.2 Bio Kangtai Hepatitis A and B Vaccine Business Overview
7.11.3 Bio Kangtai Hepatitis A and B Vaccine Major Product Offerings
7.11.4 Bio Kangtai Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 Bio Kangtai Key News
7.12 Dynavax
7.12.1 Dynavax Corporate Summary
7.12.2 Dynavax Hepatitis A and B Vaccine Business Overview
7.12.3 Dynavax Hepatitis A and B Vaccine Major Product Offerings
7.12.4 Dynavax Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Dynavax Key News
7.13 Hissen
7.13.1 Hissen Corporate Summary
7.13.2 Hissen Hepatitis A and B Vaccine Business Overview
7.13.3 Hissen Hepatitis A and B Vaccine Major Product Offerings
7.13.4 Hissen Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Hissen Key News
7.14 LG Life Sciences
7.14.1 LG Life Sciences Corporate Summary
7.14.2 LG Life Sciences Business Overview
7.14.3 LG Life Sciences Hepatitis A and B Vaccine Major Product Offerings
7.14.4 LG Life Sciences Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.14.5 LG Life Sciences Key News
7.15 Serum Institute
7.15.1 Serum Institute Corporate Summary
7.15.2 Serum Institute Business Overview
7.15.3 Serum Institute Hepatitis A and B Vaccine Major Product Offerings
7.15.4 Serum Institute Hepatitis A and B Vaccine Sales and Revenue in Global (2017-2022)
7.15.5 Serum Institute Key News
8 Global Hepatitis A and B Vaccine Production Capacity, Analysis
8.1 Global Hepatitis A and B Vaccine Production Capacity, 2017-2028
8.2 Hepatitis A and B Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis A and B Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis A and B Vaccine Supply Chain Analysis
10.1 Hepatitis A and B Vaccine Industry Value Chain
10.2 Hepatitis A and B Vaccine Upstream Market
10.3 Hepatitis A and B Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis A and B Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hepatitis A and B Vaccine in Global Market
Table 2. Top Hepatitis A and B Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Hepatitis A and B Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Hepatitis A and B Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Hepatitis A and B Vaccine Sales by Companies, (Units), 2017-2022
Table 6. Global Hepatitis A and B Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Hepatitis A and B Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Hepatitis A and B Vaccine Product Type
Table 9. List of Global Tier 1 Hepatitis A and B Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis A and B Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hepatitis A and B Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Hepatitis A and B Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Hepatitis A and B Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Hepatitis A and B Vaccine Sales (Units), 2017-2022
Table 15. By Type - Global Hepatitis A and B Vaccine Sales (Units), 2023-2028
Table 16. By Application ? Global Hepatitis A and B Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Hepatitis A and B Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Hepatitis A and B Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Hepatitis A and B Vaccine Sales (Units), 2017-2022
Table 20. By Application - Global Hepatitis A and B Vaccine Sales (Units), 2023-2028
Table 21. By Region ? Global Hepatitis A and B Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Hepatitis A and B Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Hepatitis A and B Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Hepatitis A and B Vaccine Sales (Units), 2017-2022
Table 25. By Region - Global Hepatitis A and B Vaccine Sales (Units), 2023-2028
Table 26. By Country - North America Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Hepatitis A and B Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Hepatitis A and B Vaccine Sales, (Units), 2017-2022
Table 29. By Country - North America Hepatitis A and B Vaccine Sales, (Units), 2023-2028
Table 30. By Country - Europe Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Hepatitis A and B Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Hepatitis A and B Vaccine Sales, (Units), 2017-2022
Table 33. By Country - Europe Hepatitis A and B Vaccine Sales, (Units), 2023-2028
Table 34. By Region - Asia Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Hepatitis A and B Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Hepatitis A and B Vaccine Sales, (Units), 2017-2022
Table 37. By Region - Asia Hepatitis A and B Vaccine Sales, (Units), 2023-2028
Table 38. By Country - South America Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Hepatitis A and B Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Hepatitis A and B Vaccine Sales, (Units), 2017-2022
Table 41. By Country - South America Hepatitis A and B Vaccine Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Hepatitis A and B Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Hepatitis A and B Vaccine Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Hepatitis A and B Vaccine Sales, (Units), 2023-2028
Table 46. GSK Corporate Summary
Table 47. GSK Hepatitis A and B Vaccine Product Offerings
Table 48. GSK Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Hepatitis A and B Vaccine Product Offerings
Table 51. Merck Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Hepatitis A and B Vaccine Product Offerings
Table 54. Sanofi Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Sinovac Corporate Summary
Table 56. Sinovac Hepatitis A and B Vaccine Product Offerings
Table 57. Sinovac Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Zhejiang Pukang Corporate Summary
Table 59. Zhejiang Pukang Hepatitis A and B Vaccine Product Offerings
Table 60. Zhejiang Pukang Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Changchun Institute of Biological Corporate Summary
Table 62. Changchun Institute of Biological Hepatitis A and B Vaccine Product Offerings
Table 63. Changchun Institute of Biological Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. KM Biologics Corporate Summary
Table 65. KM Biologics Hepatitis A and B Vaccine Product Offerings
Table 66. KM Biologics Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. IMBCAMS Corporate Summary
Table 68. IMBCAMS Hepatitis A and B Vaccine Product Offerings
Table 69. IMBCAMS Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Convac Corporate Summary
Table 71. Convac Hepatitis A and B Vaccine Product Offerings
Table 72. Convac Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. NCPC Corporate Summary
Table 74. NCPC Hepatitis A and B Vaccine Product Offerings
Table 75. NCPC Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Bio Kangtai Corporate Summary
Table 77. Bio Kangtai Hepatitis A and B Vaccine Product Offerings
Table 78. Bio Kangtai Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Dynavax Corporate Summary
Table 80. Dynavax Hepatitis A and B Vaccine Product Offerings
Table 81. Dynavax Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Hissen Corporate Summary
Table 83. Hissen Hepatitis A and B Vaccine Product Offerings
Table 84. Hissen Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. LG Life Sciences Corporate Summary
Table 86. LG Life Sciences Hepatitis A and B Vaccine Product Offerings
Table 87. LG Life Sciences Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Serum Institute Corporate Summary
Table 89. Serum Institute Hepatitis A and B Vaccine Product Offerings
Table 90. Serum Institute Hepatitis A and B Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Hepatitis A and B Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 92. Global Hepatitis A and B Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Hepatitis A and B Vaccine Production by Region, 2017-2022 (Units)
Table 94. Global Hepatitis A and B Vaccine Production by Region, 2023-2028 (Units)
Table 95. Hepatitis A and B Vaccine Market Opportunities & Trends in Global Market
Table 96. Hepatitis A and B Vaccine Market Drivers in Global Market
Table 97. Hepatitis A and B Vaccine Market Restraints in Global Market
Table 98. Hepatitis A and B Vaccine Raw Materials
Table 99. Hepatitis A and B Vaccine Raw Materials Suppliers in Global Market
Table 100. Typical Hepatitis A and B Vaccine Downstream
Table 101. Hepatitis A and B Vaccine Downstream Clients in Global Market
Table 102. Hepatitis A and B Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis A and B Vaccine Segment by Type
Figure 2. Hepatitis A and B Vaccine Segment by Application
Figure 3. Global Hepatitis A and B Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis A and B Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis A and B Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Hepatitis A and B Vaccine Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis A and B Vaccine Revenue in 2021
Figure 9. By Type - Global Hepatitis A and B Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Hepatitis A and B Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Hepatitis A and B Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Hepatitis A and B Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Hepatitis A and B Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Hepatitis A and B Vaccine Sales Market Share, 2017-2028
Figure 19. US Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Hepatitis A and B Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Hepatitis A and B Vaccine Sales Market Share, 2017-2028
Figure 33. China Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Hepatitis A and B Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Hepatitis A and B Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Hepatitis A and B Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Hepatitis A and B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Hepatitis A and B Vaccine Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Hepatitis A and B Vaccine by Region, 2021 VS 2028
Figure 50. Hepatitis A and B Vaccine Industry Value Chain
Figure 51. Marketing Channels
